JPMorgan analyst Yang Huang initiated coverage of Ascentage Pharma (AAPG) with an Overweight rating and HK$52 price target The company’s Olverembatinib, having been approved for three CML ...

PHOENIX, March 7, 2025 /PRNewswire/ -- BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in wound healing and wound care products, is proud to announce its partnership and ...

Investment and Partnership will Allow Manufacturer to Create New Wound Care Products Using Fish Collagen PHOENIX, March 7, 2025 /PRNewswire/ -- BioLab Holdings, Inc., a Phoenix-based medical ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of $180.00. The company’s shares closed last Friday at ...

Ajinomoto Bio-Pharma Services recognized in "Global Biologics" category Forge Biologics, a member of Ajinomoto-Bio-Pharma Services, recognized in "Global Cell & Gene Therapy" category SAN DIEGO ...

PHOENIX, March 25, 2025 /PRNewswire/ -- BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in wound healing and wound care products, is proud to announce the establishment of ...

BridgeBio Pharma has a fifty-two week low of $21.62 and a fifty-two week high of $39.47. The company has a market cap of $6.61 billion, a PE ratio of -12.20 and a beta of 1.07.

In the last few weeks, it also imposed tariffs of 20% on all imports from China, a major supplier of ingredients and other materials used in the pharma industry, and threatened a flat 25% rate on ...

Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...

PHOENIX, March 25, 2025 /PRNewswire/ -- BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in wound healing and wound care products, is proud to announce the establishment of its ...